169 related articles for article (PubMed ID: 16076703)
1. Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublines.
Tieva A; Bergh A; Damber JE
Acta Oncol; 2005; 44(3):299-303. PubMed ID: 16076703
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone receptor expression in the human prostate.
Tieva A ; Stattin P; Wikström P; Bergh A; Damber JE
Prostate; 2001 Jun; 47(4):276-84. PubMed ID: 11398175
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondins, metallo proteases and thrombospondin receptors messenger RNA and protein expression in different tumour sublines of the Dunning prostate cancer model.
Vallbo C; Damber JE
Acta Oncol; 2005; 44(3):293-8. PubMed ID: 16076702
[TBL] [Abstract][Full Text] [Related]
4. Expression of gonadotropin-releasing hormone receptor mRNA in the rat ventral prostate and dunning R3327 PAP adenocarcinoma before and after castration.
Tieva A; Wilkström P; Olofsson JI; Bergh A; Damber JE
Prostate; 1999 May; 39(2):101-7. PubMed ID: 10221565
[TBL] [Abstract][Full Text] [Related]
5. Detection of mRNA expression of gonadotropin-releasing hormone and its receptor in normal and neoplastic rat prostates.
Lau HL; Zhu XM; Leung PC; Chan LW; Chen GF; Chan PS; Yu KL; Chan FL
Int J Oncol; 2001 Dec; 19(6):1193-201. PubMed ID: 11713589
[TBL] [Abstract][Full Text] [Related]
6. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
Wikström P; Lindh G; Bergh A; Damber JE
Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of luteinizing hormone-releasing hormone receptor gene messenger RNA expression in hormone-refractory human prostate cancers.
Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K
Clin Cancer Res; 2001 Aug; 7(8):2340-3. PubMed ID: 11489810
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of androgen receptor in the R-3327 Dunning rat prostatic adenocarcinoma.
Quarmby VE; Beckman WC; Cooke DB; Lubahn DB; Joseph DR; Wilson EM; French FS
Cancer Res; 1990 Feb; 50(3):735-9. PubMed ID: 2404576
[TBL] [Abstract][Full Text] [Related]
9. Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors.
Halin S; Wikström P; Rudolfsson SH; Stattin P; Doll JA; Crawford SE; Bergh A
Cancer Res; 2004 Aug; 64(16):5664-71. PubMed ID: 15313905
[TBL] [Abstract][Full Text] [Related]
10. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma.
Castellón E; Clementi M; Hitschfeld C; Sánchez C; Benítez D; Sáenz L; Contreras H; Huidobro C
Cancer Invest; 2006; 24(3):261-8. PubMed ID: 16809153
[TBL] [Abstract][Full Text] [Related]
11. High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers.
Halmos G; Arencibia JM; Schally AV; Davis R; Bostwick DG
J Urol; 2000 Feb; 163(2):623-9. PubMed ID: 10647698
[TBL] [Abstract][Full Text] [Related]
12. The significance of LMO2 expression in the progression of prostate cancer.
Ma S; Guan XY; Beh PS; Wong KY; Chan YP; Yuen HF; Vielkind J; Chan KW
J Pathol; 2007 Feb; 211(3):278-85. PubMed ID: 17167821
[TBL] [Abstract][Full Text] [Related]
13. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors.
Powell CT; Fair WR; Heston WD
Cell Growth Differ; 1994 Feb; 5(2):143-9. PubMed ID: 8180127
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin releasing hormone receptor gene and protein expression and immunohistochemical localization in bovine uterus and oviducts.
Singh R; Graves ML; Roskelley CD; Giritharan G; Rajamahendran R
Domest Anim Endocrinol; 2008 Apr; 34(3):319-26. PubMed ID: 18035513
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor content in metastasizing and nonmetastasizing Dunning prostatic adenocarcinoma.
Häggström S; Bergh A; Damber JE
Prostate; 2000 Sep; 45(1):42-50. PubMed ID: 10960841
[TBL] [Abstract][Full Text] [Related]
18. [Epidermal growth factor up-regulates the mRNA expression of endothelin-1 and its receptors in prostate cancer PC-3 cell lines].
Jia RP; Jiang YF; Xu LW; Wang SK; Wang ZZ; Li WC; He BS
Zhonghua Nan Ke Xue; 2008 Jan; 14(1):15-9. PubMed ID: 18297804
[TBL] [Abstract][Full Text] [Related]
19. Daily GnRH and GnRH-receptor mRNA expression in the ovariectomized and intact rat.
Schirman-Hildesheim TD; Ben-Aroya N; Koch Y
Mol Cell Endocrinol; 2006 Jun; 252(1-2):120-5. PubMed ID: 16672174
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
